Imbruvica Shows Response in 2/3 of Steroid Dependent, Refractory cGVHD Patients in Phase II Study December 22, 2016Vol.39 No.11
Tagrisso Shows Superiority vs. Chemo in EGFR T790M Mutation-Positive Disease December 22, 2016Vol.39 No.11
Study met Primary Endpoint of Non-Inferiority Versus Zoledronic Acid in Delaying Skeletal-Related Events November 29, 2016Vol.39 No.10
High-Dose Chemo and Stem Cell Transplant Cures Most Relapsed Testis Cancer November 29, 2016Vol.39 No.10
